FDA Approves Alcon’s Eye Stent

The FDA approved Alcon Laboratories’ CyPass System – a tiny stent implanted into the eye to drain fluid in patients with glaucoma.

The CyPass System consists of a micro stent that is pre-loaded into a stent-delivery tool. The stent is designed to control intraocular pressure (IOP) by creating a drainage pathway from the anterior chamber to the outermost layer of the eye.

Clinical trials in 374 patients implanted with the device saw 72.5 percent achieve IOP compared to 58 percent who received cataract surgery alone. — Tamra Sami